Yung Shin Pharmaceutical Hit by Cyberattack in First Material Cybersecurity Filing by a Non-Listed Public Company

According to iThome, Taiwanese pharmaceutical manufacturer Yung Shin Pharmaceutical Industrial Co., Ltd. (永信藥品工業) suffered a cybersecurity incident: its listed parent company, YungShin Global Holding Corporation (永信投控), first disclosed the matter at 4:32 p.m. on June 17 via the TWSE Market Observation Post System (MOPS) on behalf of its major subsidiary, and at 6:00 p.m. the same day Yung Shin Pharmaceutical—a public reporting company—also issued its own material announcement disclosing the cyberattack on parts of its IT systems ^[1]. Regarding response measures, Yung Shin Pharmaceutical stated that its IT department immediately activated defense mechanisms and recovery operations upon detecting the attack, assessing no material impact on operations ^[1]. The company added that it is conducting comprehensive scans across all domains, web pages, and related files and will progressively restore IT systems once security is confirmed ^[1].

Industries mainly affected: Healthcare

The company added that it is conducting comprehensive scans across all domains, web pages, and related files and will progressively restore IT systems once security is confirmed ^[1].